May 2025 – Present · 10 mos

Jan 2022 – Present · 4 yrs 2 mos

• Inito is a Y Combinator backed health tech startup that helps consumers learn more about their body and get actionable insights to achieve their health goals.
• We are building a platform that allows diagnostic tests on fertility, diabetes, high cholesterol, infections and more on a smartphone with lab grade accuracy. Our tight integration of proprietary hardware, biotechnology, computer vision algorithms and machine learning makes it possible for consumers to not just get data about their body but also an analysis of what it means.
• Every human being needs access to healthcare and data about their body parameters. Our vision is to give people insights about their body in every household - just like a thermometer does today.
• Our users have taken over 1 million tests for our first use case - monitoring fertility hormones. This largest dataset of fertility hormones in the world helps us suggest fertile days, confirm Ovulation and manage conditions like PCOS.
• The Inito App was featured on the Apple App Store twice in 2020. In 2021, we became the first home device from India to clear the US FDA Regulatory Pathway.
• On the back of strong product-market fit and US Launch, our revenue grew 7X in 2022. Our focus in 2023 is to heavily invest in our engineering, product and data science capability to allow users to get deeper insights from their data, expand to use cases beyond fertility hormone testing and establish ourselves as a leader in this massive market ripe for disruption!.